NEWS
New Feature!!!! University Subject Rankings in 12 branches
FOR SCIENTIST REGISTRATION FOR INSTITUTIONAL BULK REGISTRATION
FOR EDIT YOUR UNIVERSITY / INSTITUTION PAGE
Some differences of the AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
List without CERN, Statistical Data etc. Only in AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
AD
Scientific Index 2024
About Us
Methodology
Compare & Choose
Contact - FAQ
login
Login
person_add
Register
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
school
University Rankings
subject
University Subject Rankings
insights
Subject Rankings
place
Country Rankings
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
local_fire_department
Country Top Lists
Zeynep Busra Zengin
Beckman Research Institute of City of Hope - Kaliforniya / United States
Others
AD Scientific Index ID: 5406781
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Zeynep Busra Zengin's MOST POPULAR ARTICLES
1-)
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trialN Dizman, L Meza, P Bergerot, M Alcantara, T Dorff, Y Lyou, P Frankel, ...Nature medicine 28 (4), 704-712, 20222532022
2-)
Targeted therapies: Expanding the role of FGFR3 inhibition in urothelial carcinomaZB Zengin, A Chehrazi-Raffle, NJ Salgia, R Muddasani, S Ali, L Meza, ...Urologic Oncology: Seminars and Original Investigations 40 (2), 25-36, 2022182022
3-)
Tivozanib in renal cell carcinoma: a new approach to previously treated diseaseNJ Salgia, ZB Zengin, SK PalTherapeutic advances in medical oncology 12, 1758835920923818, 2020162020
4-)
Effect of CBM588 in combination with cabozantinib plus nivolumab for patients (pts) with metastatic renal cell carcinoma (mRCC): A randomized clinical trial.H Ebrahimi, LA Meza, K Lee, J Malhotra, M Alcantara, ZB Zengin, ...Journal of Clinical Oncology 41 (17_suppl), LBA104-LBA104, 2023132023
5-)
Complementary role of circulating tumor DNA assessment and tissue genomic profiling in metastatic renal cell carcinomaZB Zengin, C Weipert, NJ Salgia, N Dizman, J Hsu, L Meza, ...Clinical Cancer Research 27 (17), 4807-4813, 2021122021
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept